Name | Lb Broen Home |
---|---|
Location | 824 South Sheridan, Fergus Falls, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 78 |
Occupancy Rate | 79.49% |
Medicare ID (CCN) | 245453 |
Legal Business Name | Lutheran Brethren Retirement Services Inc |
Ownership Type | Non Profit - Corporation |
NPI Number | 1053307793 |
Organization Name | LUTHERAN BRETHREN RETIREMENT SERVICES INC |
Doing Business As | LB BROEN HOME |
Address | 824 S Sheridan St, Fergus Falls, MN 56537 |
Phone Number | 218-998-7300 |
News Archive
Known nationally for her research into single-cell organisms that affect oral health, Millicent "Mimi" Goldschmidt, Ph.D., a professor of microbiology and molecular genetics at The University of Texas Health Science Center at Houston (UTHealth), has been selected to receive the 2011 American Society for Microbiology (ASM) Founders Distinguished Service Award.
The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Research Institute (DCRI).
"An initiative announced [Thursday] in London by the Group of Eight (G8) industrialized countries to ramp up the fight against rape and other sexual violence in conflict represents 'a beacon of light and hope' for the countless survivors around the world," the U.N. Secretary General's Special Representative on Sexual Violence in Conflict Zainab Hawa Bangura said at the launch of the Declaration on Preventing Sexual Violence, the U.N. News Centre reports (4/11).
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
The discovery identifies an adaptation by cancer cells that facilitates their spreading to distant sites, and the potential for targeting these features to prevent or slow the progression of metastatic hormone receptor-positive breast cancer.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Known nationally for her research into single-cell organisms that affect oral health, Millicent "Mimi" Goldschmidt, Ph.D., a professor of microbiology and molecular genetics at The University of Texas Health Science Center at Houston (UTHealth), has been selected to receive the 2011 American Society for Microbiology (ASM) Founders Distinguished Service Award.
The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Research Institute (DCRI).
"An initiative announced [Thursday] in London by the Group of Eight (G8) industrialized countries to ramp up the fight against rape and other sexual violence in conflict represents 'a beacon of light and hope' for the countless survivors around the world," the U.N. Secretary General's Special Representative on Sexual Violence in Conflict Zainab Hawa Bangura said at the launch of the Declaration on Preventing Sexual Violence, the U.N. News Centre reports (4/11).
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
The discovery identifies an adaptation by cancer cells that facilitates their spreading to distant sites, and the potential for targeting these features to prevent or slow the progression of metastatic hormone receptor-positive breast cancer.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 9.57 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.91 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.97 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.56 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.7 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.35 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.7 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.18 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 9.79 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 89.73 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 21.25 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 1.86 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.52 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.17 | 95.98 |
Percentage of short-stay residents who made improvements in function | 79.26 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 68.58 | 82.93 |
News Archive
Known nationally for her research into single-cell organisms that affect oral health, Millicent "Mimi" Goldschmidt, Ph.D., a professor of microbiology and molecular genetics at The University of Texas Health Science Center at Houston (UTHealth), has been selected to receive the 2011 American Society for Microbiology (ASM) Founders Distinguished Service Award.
The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Research Institute (DCRI).
"An initiative announced [Thursday] in London by the Group of Eight (G8) industrialized countries to ramp up the fight against rape and other sexual violence in conflict represents 'a beacon of light and hope' for the countless survivors around the world," the U.N. Secretary General's Special Representative on Sexual Violence in Conflict Zainab Hawa Bangura said at the launch of the Declaration on Preventing Sexual Violence, the U.N. News Centre reports (4/11).
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
The discovery identifies an adaptation by cancer cells that facilitates their spreading to distant sites, and the potential for targeting these features to prevent or slow the progression of metastatic hormone receptor-positive breast cancer.
› Verified 1 days ago
Pioneer Care Center Location: 1131 South Mabelle Avenue, Fergus Falls, Minnesota 56537 Phone: (218) 998-1500 | |
Mn Veterans Home Fergus Falls Location: 1821 North Park, Fergus Falls, Minnesota 56537 Phone: (218) 736-0400 |